> ## Content Index
> Fetch the complete content index at: https://www.coios.me/llms.txt
> Use this file to discover other available public pages before exploring further.

# Cervical cancer screening rises but gaps persist in US medical records, 2019-2024
- URL: https://www.coios.me/cervical-cancer-screening-rises-but-gaps-persist-in-us/
- Published: 2026-10-17T09:00:19.000Z
- Updated: 2026-10-17T09:55:19.000Z
- Description: Screening rates rose in all racial and ethnic groups from 2019 to 2024, with the largest gain among Hispanic patients.
- Author: Daniel Ryan
- Tags: Data, models and systems, Health systems and access, Cancer, Infection and pandemics, United States, #peer-reviewed, #confirms, #item, #source-2026-10, #score-55

This cross-sectional study used a US electronic medical record database to measure cervical cancer screening rates. Female patients aged 21 to 64 were included annually from 2019 to 2024, with 9 to 16 million per year. Rates were stratified by race and ethnicity, age, language and census region, with trends tested by Cochran-Armitage. Screening rose from 10.98% to 13.85% in non-Hispanic White patients and from 9.85% to 15.51% in Hispanic patients. American Indian, Alaska Native, Native Hawaiian and Pacific Islander patients had the lowest rates in every year, and so did the Western and Southern regions. Rates cover only those with a recorded health care encounter, not the wider population.

*Why it is interesting: Screening uptake and the differences between groups shape which cervical cancers are found early. The data cover the pandemic period and the years after it.*

Source

[JAMA Network Open, 16 October 2026](https://doi.org/10.1001/jamanetworkopen.2026.39938?ref=coios.me)

Paper

Cervical Cancer Screening Rates by Race and Ethnicity, Age, Language, and Census Region

Authors

Xie Y, Nguyen L, Le YC, Zamorano A

DOI

10.1001/jamanetworkopen.2026.39938

Type

Peer-reviewed article

Design

Repeated cross-sectional analysis of a US electronic medical record database, women aged 21-64, approximately 9-16 million patients per year, 2019-2024

Verdict

Confirms prior evidence

Driver

[Health systems and access](https://www.coios.me/d-health-systems/)

Driver

[Cancer](https://www.coios.me/d-cancer/)

Driver

[Infection and pandemics](https://www.coios.me/d-infectious-disease/)